ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

As previously disclosed, on October 28, 2021, Integra LifeSciences Holdings Corporation (the "Company") announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer. In connection with his appointment as President and Chief Executive Officer of the Company, the Board of Directors of the Company (the "Board") also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment.

On December 1, 2021, Mr. De Witte commenced employment with the Company as its President and Chief Executive Officer and was appointed as a director of the Board, with his term as a director expiring at the Company's 2022 annual meeting of stockholders.

In connection with the commencement of Mr. De Witte's employment as President and Chief Executive Officer of the Company, Peter J. Arduini's previously-announced resignation from his position as President and Chief Executive Officer and a director of the Company became effective as of December 1, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses